Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1,045.59 | 478.65 | 228.42¢ | 3.8 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 380.41 | 57.10 | 24.03¢ | 36.4 | n/a | -90% | n/a | 0.0% |
31-Dec-27 | 280.15 | (21.31) | (28.22)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Local Digest | 10-May-2009 | Washington Post |
Novavax Moves Closer to Licensing Bird Flu Vaccine | 27-Aug-2008 | Washington Post |
Business Briefing | 09-Aug-2008 | Washington Post |
Currency | US Dollars |
Share Price | $ 7.73 |
Change Today | $ -1.01 |
% Change | -11.56 % |
52 Week High | $14.68 |
52 Week Low | $5.39 |
Volume | 15,458,711 |
Shares Issued | 23.47m |
Market Cap | $181.45m |
RiskGrade | 720 |
Strong Buy | 2 |
Buy | 2 |
Neutral | 2 |
Sell | 1 |
Strong Sell | 1 |
Total | 8 |
Time | Volume / Share Price |
14:34 | 200 @ $7.73 |
14:34 | 200 @ $7.73 |
14:34 | 100 @ $7.73 |
14:34 | 100 @ $7.73 |
14:33 | 100 @ $7.73 |
You are here: research